Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 19, 2011
Florida Hospital for Children and Cord Blood Registry® (CBR) have launched a FDA-regulated, Phase I safety study of the use of cord blood stem cells to treat children with sensorineural hearing loss.
Approximately 15 percent of children in the U.S. suffer from low or high-frequency hearing loss. The most common type of hearing loss, especially at high frequencies, is sensorineural. Acquired sensorineural hearing loss results from damage to hair cells in the inner ear (cochlea) and can be caused by illness, medication, noise exposure, birth injury, or head trauma.